NCT00322231已完成3 期
A Phase III Clinical Trial to Study the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live in Subjects With a History of Herpes Zoster
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 101
- 主要终点
- Vaccine-related Serious Adverse Experiences (SAEs) for 28 Days Postvaccination
研究概览
简要总结
The purpose of this study is to determine whether the investigational zoster vaccine, is generally well tolerated when administered to participants with a history of herpes zoster.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults ≥ 50 years of age with a history of herpes zoster ≥ 5 years prior to enrollment
排除标准
- •History of allergy to any vaccine component
- •Prior receipt of a varicella or zoster vaccine
- •Ability to defend against infection is suppressed by a medical condition or medication
结局指标
主要结局
Vaccine-related Serious Adverse Experiences (SAEs) for 28 Days Postvaccination
时间窗: To Day 28 postvaccination
SAEs are AEs at any dose that: Results in death or persistent/significant disability/incapacity; or prolongs an existing inpatient hospitalization or Is life threatening; or Is a congenital anomaly/birth defect; or Is a cancer; or Is an overdose or Is an other important medical event
次要结局
- Geometric Mean Titer (GMT) of Varicella-zoster Virus (VZV) Antibody Responses at 4 Weeks Postvaccination(4 weeks postvaccination)
- Geometric Mean Fold Rise (GMFR) in VZV Antibody Titers From Prevaccination to 4 Weeks Postvaccination(From prevaccination (baseline) to 4 weeks postvaccination)
研究者
相似试验
已完成
3 期
A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)Herpes ZosterNCT00231816Merck Sharp & Dohme LLC763
已完成
3 期
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult VolunteersInfluenzaNCT01987011Green Cross Corporation420
已完成
3 期
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV DiseaseRESPIRATORY SYNCYTIAL VIRUS (RSV)NCT05842967Pfizer885
已完成
3 期
Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)ShinglesHerpes ZosterNCT01527370Merck Sharp & Dohme LLC250
已完成
3 期
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy InfantsHaemophilus Influenzae Type bNCT01000974GlaxoSmithKline4,003